LOS ANGELES, Sept. 24, 2020 /PRNewswire-PRWeb/ -- The
patent holder of QVS-96S, TCI Gene, Inc., announced that they have
a global distribution agreement with Dr. David Allen, CEO of World Wellness and
Lindsey Carnett, CEO and President
of Marketing Maven to be Authorized Agents to represent, promote,
import, and sell the product. The creator of QVS-96S is based in
Taiwan and sought out this
distribution arrangement based on the following partner channels
held by Dr. Allen and Carnett: hospitals, laboratories, fitness,
education, municipalities, insurance companies, genetics, medical
device, airports and government agencies.
Novel coronavirus (COVID-19) tests are conducted in commercial,
private and academic labs, as well as state and county health labs.
The global pandemic has emerged as one of the most significant
humanitarian challenges in recent history, and testing is seen as
one of the main components of efforts to contain the virus and
mitigate its impact.
QVS-96S is the world's first fully automated virus scanner
operated by robotic arms, to load the corresponding codes of the
specimens, which can prevent mismatches between test results and
specimens caused by human error.
After specimens are handled, they are tested in a fully
automatic, unmanned, and zero-pollution environment with the qPCR
detection technology with an accuracy rate of 99.99%. The test
results of 96 specimens can be obtained in under three hours and 30
minutes, and thereafter every 50 minutes to achieve 24/7
comprehensive monitoring and prompt responses to the pandemic.
QVS-96 is based on Nobel-prize winning Polymerase Chain Reaction
Technology (PCR). PCR quickly replicates a single specific fragment
of DNA or RNA to quantities sufficient for accurate laboratory
analysis.
In June 2020, this device received
Certification of FDA Registration. Most importantly, they are
listed on the FDA's website as an Establishment Registration and
Device Listing:
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=685117&lpcd=JTC
"According to former Food and Drug Administration Commissioner
Dr. Scott Gottlieb, as coronavirus
outbreaks continue to grow across a number of states, the U.S.
response is still hampered by a lack of testing," said Dr.
Allen.
Jason Lin, the sales
representative for TCI Gene stated, "We consider this QVS-96
machine an efficient tool that may assist countries in need of
rapidly expanding accurate testing capacity during this difficult
time."
QVS-96S, the fully automated detection integration system,
allows a turnaround time of qPCR 10 times faster than the original
testing process, is now listed by the FDA. With a high capacity of
PCR test power and shortness of timing, QVS-96S performance is
nominated in well-known scientific journals like "Nature
Biotechnology" to be deemed as effective to inform consumers with
data quickly and accurately.
For more information about the QVS-96S and how it can be
purchased, contact David Allen at
drdavidallen@gmail.com or Lindsey
Carnett at lindsey@marketingmaven.com.
About TCI Gene, Inc.
A World TOP 3 Pharmaceutical and cosmeceutical ODM manufacturer TCI
has created a large variety of best-selling products for customers
in 54 countries. Hundreds of millions of healthy foods in tablets
and capsules, tens of millions of bottles of functional drinks and
millions of facial masks and essences have been produced annually,
serving 75% of the world's population. With strong scientific
research capabilities, TCI has obtained 600 patents worldwide, and
its long-term remarkable profit and operating performance has got
it listed in Forbes ASIA'S 200
BEST UNDER A BILLION for four times. A decade ago, TCI entered the
field of genetics and founded TCI Gene, dedicated to the
development of genetic testing and personalized health care
products, and joined stem cell therapy to offer a health total
solution for customer. Since the outbreak of Covid-19, TCI Gene had
gained the insight that the success of improving the prevention and
control system lies in bolstering preparedness and response
capacity. In short of time, developed the full-automation nucleic
acid testing plate-from "QVS-96S".
About Marketing Maven
With offices in Los Angeles and
New York, Marketing Maven is a
full-service marketing and communications agency. With origins in
direct response public relations, Marketing Maven has developed
into a premier voice in brand strategy, social media, innovative
media relations, event marketing, tradeshow support, Hispanic
marketing and search engine optimization. Marketing Maven leads the
industry in utilizing advanced metrics to measure their clients'
marketing reach and providing competitive analysis unparalleled in
the industry. For additional information about Marketing Maven,
visit http://www.MarketingMaven.com.
About Dr. David Allen
Dr. David Allen is Chairman and CEO
of World Wellness, LLC, a San
Diego based Bioscience Company focused on bringing new
technologies and products to the marketplace. Dr. Allen has
provided over 25 years of expertise in developing, marketing and
placing clinically tested patented technology for multi-channel
distribution. David is the President of the American Botanical Drug
Association. The global market for botanical and plant-derived
drugs expected to grow to $39.6B by
2022 with a compound annual growth rate (CAGR) of 6.1%. The US FDA
Botanical Drug Development Guidance for Industry defines a pathway
for herbal medicines to become prescription drugs in the US. For
more info on Dr. Allen and World Wellness, LLC, please visit
https://www.worldwellness.us/.
SOURCE TCI Gene, Inc.